Tokyo, Aug. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058712) titled 'Therapeutic Option for Nintedanib related diArrhea in patients with progressive fibrosing interstitial lung disease a multicenter Clinical triAl' on Aug. 6.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Open -no one is blinded
Control - Dose comparison
Primary Sponsor:
Institute - Shinmatsudo central general Hospital
Condition:
Condition - Patients with PF-ILD, excluding scleroderma
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Validating the nintedanib dose reduction group versus MiyaBM addition group tre...